Source comparison
Loading Phase Versus Maintenance Dosing
The loading phase exists because TB-500 doesn't produce acute effects. It modulates healing over weeks, not days. Initial high-dose administration (5–10mg weekly) saturates tissue with thymosin beta-4, establishing a baseline concentration that accelerates rep
This comparison does not assign a generated winner or score.
- The loading phase exists because TB-500 doesn't produce acute effects. It modulates healing over weeks, not days. Initial high-dose administration (5–10mg weekly) saturates tissue with thymosin beta-4, establishing a baseline concentration that accelerates repair cell recruitment. Without loading, therapeutic effects take 6–8 weeks to manifest; with loading, athletes report functional improvement within 10–14 days.
- Maintenance dosing (2–5mg weekly) sustains that baseline without oversaturation. Once repair cells have migrated to injury sites and collagen remodelling begins, lower doses are sufficient to support ongoing healing. Extending high-dose protocols beyond six weeks doesn't accelerate recovery further. It just increases cost without added benefit. Our experience across research analysis shows athletes who skip maintenance and stop after loading often see incomplete healing, with symptoms returning under full training loads.
- Dose frequency within the week also matters. Splitting 10mg into two 5mg injections (Monday/Thursday) produces smoother plasma levels than a single 10mg injection. TB-500 has a half-life of approximately 7–10 days in circulation, meaning weekly dosing maintains therapeutic concentration, but splitting doses reduces peak-to-trough variation. For athletes training six days per week, consistent peptide levels translate to more predictable recovery timing.